Receptor activator of nuclear factor kappa-B ligand (RANKL), a key factor of osteoclasts, exhibits high expression in lytic bone tumors and promotes the continuous proliferation and differentiation of osteoclasts. The gene discussed is TNFSF11; the disease is bone neoplasm.